CUAMC
ARCT icon

China Universal Asset Management Company’s Arcturus Therapeutics ARCT Stock Holding History

China Universal Asset Management Company’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.9K Buy
5,042
+412
+9% +$3.01K ﹤0.01% 471
2025
Q4 		$28.4K Sell
4,630
-3,130
-40% -$33.8K ﹤0.01% 480
2025
Q3 		$143K Buy
7,760
+2,313
+42% +$37.2K 0.01% 358
2025
Q2 		$70.9K Buy
5,447
+14
+0.3% +$166 0.01% 391
2025
Q1 		$57.5K Sell
5,433
-311
-5% -$4.94K 0.01% 407
2024
Q4 		$97.5K Buy
5,744
+543
+10% +$10.2K 0.01% 394
2024
Q3 		$121K Buy
5,201
+2,038
+64% +$43.6K 0.01% 342
2024
Q2 		$77K Sell
3,163
-1,990
-39% -$60.3K 0.01% 317
2024
Q1 		$174K Buy
5,153
+2,064
+67% +$73.1K 0.02% 308
2023
Q4 		$97.4K Buy
3,089
+2,406
+352% +$57.2K 0.02% 283
2023
Q3 		$17.5K Buy
683
+335
+96% +$10.3K 0.01% 306
2023
Q2 		$9.98K Sell
348
-12
-3% -$327 ﹤0.01% 318
2023
Q1 		$8.63K Buy
360
+91
+34% +$1.63K ﹤0.01% 311
2022
Q4 		$4.56K Buy
269
+20
+8% +$349 ﹤0.01% 309
2022
Q3 		$4K Buy
+249
New +$4.18K ﹤0.01% 288

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

China Universal Asset Management Company's ARCT Position: Q1 2026 in Review

China Universal Asset Management Company increased its Arcturus Therapeutics (ARCT) stake by 8.9% in Q1 2026, buying an estimated $3.01K and bringing the position to 5,042 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

China Universal Asset Management Company first reported a position in ARCT in Q3 2022 and has held it in 15 quarters since. The position peaked at $174K in Q1 2024. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • China Universal Asset Management Company held 5,042 shares of Arcturus Therapeutics worth $38.9K as of Q1 2026.
  • China Universal Asset Management Company bought 412 Arcturus Therapeutics shares in Q1 2026, an estimated $3.01K.
  • Arcturus Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #471 holding.
  • China Universal Asset Management Company first reported a position in Arcturus Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Arcturus Therapeutics position peaked at $174K in Q1 2024.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.